Montreal Cognitive Assessment (MoCA): Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
== Intended Population == | == Intended Population == | ||
It can be used on the following populations: | |||
* Older adults | |||
* Dementia (Alzheimer's dementia and others) | |||
* Vascular cognitive impairment | |||
* Stroke | |||
* Parkinson's disease | |||
* Huntington's disease | |||
* Schizophrenia | |||
== Method of Use == | == Method of Use == |
Revision as of 06:20, 29 March 2022
Original Editor - Arnold Fredrick D'Souza
Top Contributors - Arnold Fredrick D'Souza, Lucinda hampton, Kim Jackson and Sultan Eylem Demirhan
Objective[edit | edit source]
It was developed by Dr. Ziad S. Nasreddine and colleagues for quickly screening individuals for mild cognitive impairment.[1]
Intended Population[edit | edit source]
It can be used on the following populations:
- Older adults
- Dementia (Alzheimer's dementia and others)
- Vascular cognitive impairment
- Stroke
- Parkinson's disease
- Huntington's disease
- Schizophrenia
Method of Use[edit | edit source]
Reference[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous[edit | edit source]
Links[edit | edit source]
References[edit | edit source]
- ↑ Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9.